Matches in Nanopublications for { ?s ?p "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP19041.RAbUJsWUXcU6HKvSe7YRyPgLYocmLPDeHXSu2TdMbynpA130_assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19041.RAbUJsWUXcU6HKvSe7YRyPgLYocmLPDeHXSu2TdMbynpA130_provenance.
- NP9807.RAc_Fm0Uk3U32KXE1P_M7RPH_NtLsZvZ0LaC8Q7W4EBBE130_assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9807.RAc_Fm0Uk3U32KXE1P_M7RPH_NtLsZvZ0LaC8Q7W4EBBE130_provenance.
- assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP8198.RAWt5IYa8asib6us6UukD6ksrIexxGwLoESQIkUyCKO1s130_assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8198.RAWt5IYa8asib6us6UukD6ksrIexxGwLoESQIkUyCKO1s130_provenance.
- NP18258.RAREEYD4k528kGyi5CfhSvV9GBtyXJpC1odaAexmmkifA130_assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18258.RAREEYD4k528kGyi5CfhSvV9GBtyXJpC1odaAexmmkifA130_provenance.
- assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP13076.RAeOTjBQLilzyw2czrElOvuCHGIS5BvHsf-KS9gRwnDSA130_assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13076.RAeOTjBQLilzyw2czrElOvuCHGIS5BvHsf-KS9gRwnDSA130_provenance.
- NP13075.RAsCWTjC__xpYH7IWgWrrDLz1BDasNWD_u2lSomLSaiEQ130_assertion description "[High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13075.RAsCWTjC__xpYH7IWgWrrDLz1BDasNWD_u2lSomLSaiEQ130_provenance.